M&A volume within the Beauty Care industry remained depressed in Q3’22, down 7% from Q3’21. As anticipated, continued softness was driven primarily by increasing recession fears by both buyers and… Read more »
As a result of increasing recession fears and continued stock market volatility, the Beauty Care industry experienced a significant drop in M&A volume in Q2’22, down 20% from Q2’21 and… Read more »
As a result of increasing recession fears and continued stock market volatility, the Beauty Care industry experienced a significant drop in M&A volume in Q2’22, down 20% from Q2’21 and… Read more »
Beauty Care M&A came back down to earth in Q1’22 with 29 transactions, following the unprecedented and unsustainable volume levels seen in Q4’21. Despite the drop from Q4’21, M&A activity… Read more »
It has been a disconcerting journey through the first three quarters of 2022. We ended 2021 having survived another year of the pandemic, with equity markets at or near all-time… Read more »
Beauty Care M&A witnessed unprecedented volume in Q4’21 with a whopping 45 transactions, up over 55% from Q4’20 and 67% over Q3’21. As anticipated, record-setting deal volume was driven by… Read more »
At the start of 2022, M&A activity continued to build off the record-breaking market we experienced in 2021. As the challenges of COVID-19 receded and a more “normal” world beyond… Read more »
M&A reached a record pace by the end of 2021 and has yet to show signs of slowing. A variety of factors drove heightened deal volume in 2021, including aggressive… Read more »
2021 outpaced the prior year in annual technology M&A spend and smashed through a record number of transaction values and volume reaching nearly $1 trillion. As a result, dealmakers were… Read more »